Provided by Tiger Trade Technology Pte. Ltd.

Fractyl Health

0.4150
+0.01503.75%
Post-market: 0.43010.0151+3.64%19:59 EST
Volume:6.05M
Turnover:2.49M
Market Cap:63.50M
PE:-0.18
High:0.4262
Open:0.4031
Low:0.3901
Close:0.4000
52wk High:3.03
52wk Low:0.3772
Shares:153.00M
Float Shares:128.00M
Volume Ratio:0.39
T/O Rate:4.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3141
EPS(LYR):-1.6176
ROE:-518.40%
ROA:-51.17%
PB:-19.98
PE(LYR):-0.26

Loading ...

Fractyl Health (GUTS) Is Down 78.0% After Positive REMAIN-1 Midpoint Data And De Novo FDA Plan - Has The Bull Case Changed?

Simply Wall St.
·
Jan 31

Fractyl Health Shares Fall After Morgan Stanley Downgrade

MT Newswires Live
·
Jan 31

Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), GE Healthcare Technologies Inc (GEHC) and Apogee Therapeutics (APGE)

TIPRANKS
·
Jan 31

Fractyl Health Cut to Equal-Weight From Overweight by Morgan Stanley

Dow Jones
·
Jan 31

Morgan Stanley Downgrades Fractyl Health to Equalweight From Overweight, Cuts Price Target to $2 From $8

MT Newswires Live
·
Jan 30

NASD Most Active Issues

Dow Jones
·
Jan 30

Fractyl Health Shares Drop, Eyes New FDA Route For Its Lead Product

Benzinga_recent_news
·
Jan 30

Fractyl Health Shares Fall 64%; Co Releases Early Data on Weight Recovery After Halting Obesity Drugs

THOMSON REUTERS
·
Jan 29

BUZZ-U.S. STOCKS ON THE MOVE-Blackstone, Summit, Lockheed Martin

Reuters
·
Jan 29

BUZZ-Fractyl releases early data on weight recovery after halting obesity drugs; shares plummet

Reuters
·
Jan 29

Fractyl Health Advances Revita for Post-GLP-1 Weight Maintenance

TIPRANKS
·
Jan 29

Fractyl Health announces results from trial evaluating Revita

TIPRANKS
·
Jan 29

Fractyl Health Reports Positive Six-Month Results for Revita in Post-GLP-1 Weight Maintenance Trial

Reuters
·
Jan 29

Fractyl Health Inc - Revita Shows 4.2% Weight Regain VS 13.3% Sham

THOMSON REUTERS
·
Jan 29

Fractyl Health Inc: Expects FDA Feedback Regarding Potential for Use of De Novo Pathway in Q2 of 2026

THOMSON REUTERS
·
Jan 29

Fractyl Health Inc - Requested FDA Feedback on Revita De Novo Pathway

THOMSON REUTERS
·
Jan 29

Fractyl Health Inc - Revita-Treated Patients Show 4.5% Weight Regain VS 7.5% Sham

THOMSON REUTERS
·
Jan 29

Fractyl Health Inc. Files Initial Beneficial Ownership Statement for CFO Lara Smith Weber

Reuters
·
Jan 15

Fractyl Health Appoints Lara Smith Weber as Chief Financial Officer

Reuters
·
Jan 06

Fractyl Health Inc - Lisa Davidson Resigns as Fractyl's CFO

THOMSON REUTERS
·
Jan 06